Correction: Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension (Journal of the American College of Cardiology (2018) 71(15) (1601–1610) (S0735109718332261) (10.1016/j.jacc.2018.01.074));Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension

Journal of the American College of Cardiology

Volumn 71, Issue 15, 2018, Pages 1601-1610

  Phillips, Robert A ^a,b,c   Xu, Jiaqiong ^b,c   Peterson, Leif E ^b,c   Arnold, Ryan M ^b   Diamond, Joseph A ^d   Schussheim, Adam E ^e  

^a Houston Methodist ^*  (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^e BRIDGEPORT HOSPITAL   (United States)

Author keywords

blood pressure; cardiovascular disease risk; predictive model; SPRINT; treatment guidelines

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ACUTE KIDNEY FAILURE; AGED; ALL CAUSE MORTALITY; ARTICLE; BRADYCARDIA; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ELECTROLYTE DISTURBANCE; FAINTNESS; FALLING; FEMALE; HAZARD RATIO; HUMAN; HYPERTENSION; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK REDUCTION; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; EPIDEMIOLOGY; MORTALITY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; UNITED STATES;

AGED; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION; MALE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; UNITED STATES;

EID: 85042661536     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2018.04.003     Document Type: Erratum

References (21)

1. The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373 (2015), 2103–2116.
2. Williamson, J.D., Supiano, M.A., Applegate, W.B., et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: a randomized clinical trial. J Am Med Assoc 315 (2016), 2673–2682.
3. Whelton, P.K., Carey, R.M., Aronow, W.S., et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol, 2017 Nov 13 [E-pub ahead of print].
4. Bress, A.P., Kramer, H., Khatib, R., et al. Potential deaths averted and serious adverse events incurred from adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) intensive blood pressure regimen in the U.S: Projections from NHANES. Circulation 135 (2017), 1617–1628.
5. Burns, N.S., Miller, P.W., Learning what we didn't know—the SPRINT data analysis challenge. N Engl J Med 376 (2017), 2205–2207.
6. Goff, D.C., Lloyd-Jones, D.M., Bennett, G., et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63:Pt B (2014), 2935–2959.
7. Peterson, L.E., PIRLS: Poisson iteratively reweighted least squares computer program for additive, multiplicative, power, and non-linear models. J Stat Softw 2 (1997), 1–28.
8. Phillips, R.A., Hypertension treatment and outcomes in the era of population health, coordinated care, and Medicare Access and CHIP Reauthorization Act (MACRA). Circulation 135 (2017), 1629–1631.
9. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). J Am Med Assoc 265 (1991), 3255–3264.
10. Beckett, N.S., Peters, R., Fletcher, A.E., et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358 (2008), 1887–1898.
11. Perry, H.M. Jr., Davis, B.R., Price, T.R., et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: The Systolic Hypertension in the Elderly Program (SHEP). J Am Med Assoc 284 (2000), 465–471.
12. James, P.A., Oparil, S., Carter, B.L., et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). J Am Med Assoc 311 (2014), 507–520.
13. Wright, J.T. Jr., Fine, L.J., Lackland, D.T., Ogedegbe, G., Dennison Himmelfarb, C.R., Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view. Ann Intern Med 160 (2014), 499–503.
14. Krakoff, L.R., Gillespie, R.L., Ferdinand, K.C., et al. 2014 hypertension recommendations from the Eighth Joint National Committee panel members raise concerns for elderly black and female populations. J Am Coll Cardiol 64 (2014), 394–402.
15. Weiss, J., Freeman, M., Low, A., et al. Benefits and harms of intensive blood pressure treatment in adults aged 60 years or older: a systematic review and meta-analysis. Ann Intern Med 166 (2017), 419–429.
16. Qaseem, A., Wilt, T.J., Rich, R., et al. Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med 166 (2017), 1–26.
17. Chobanian, A.V., Hypertension in 2017—what is the right target?. JAMA 317 (2017), 579–580.
18. Sica, D.A., Phillips, R.A., White, W.B., Bisognano, J.D., Townsend, R.R., “Translational” medicine: transforming SPRINT findings into clinical practice. J Am Soc Hypertens 10 (2016), 382–386.
19. Sundström, J., Arima, H., Woodward, M., et al. Blood pressure-lowering treatment based on cardiovascular risk: A meta-analysis of individual patient data. Lancet 384 (2014), 591–598.
20. Muntner, P., Whelton, P.K., Using predicted cardiovascular disease risk in conjunction with blood pressure to guide antihypertensive medication treatment. J Am Coll Cardiol 69 (2017), 2446–2456.
21. Karmali, K.N., Ning, H., Goff, D.C., Lloyd-Jones, D.M., Identifying individuals at risk for cardiovascular events across the spectrum of blood pressure levels. J Am Heart Assoc, 4, 2015, e002126.